Distal protection device with local drug delivery to maintain patency
View Patent ↗The present invention provides for a drug delivery mechanism for use with a protection device. The protection device has an expandable filter. The drug delivery mechanism automatically delivers a drug to the filter without requiring the intervention of the operator of the protection device. The drug delivered to the filter facilitates continued filter patency during the medical procedure.
1. A vascular protection device for use in the vasculature of a patient comprising:
a hostwire having a distal portion, the hostwire interposable in the vasculature of the patient;
an expandable filter attached to a distal portion of the hostwire, the filter being expandable from a collapsed delivery configuration to an expanded deployed configuration, the filter having a proximal end, a distal end and a filtering surface for allowing passage of blood therethrough, the filtering surface not carrying a drug in the collapsed delivery configuration; and
a drug delivery mechanism carried by the hostwire adjacent the distal portion of the hostwire, the drug delivery mechanism being positioned proximal to the distal end of the filter and being spaced apart from the filtering surface of the filter when the filter is in the expanded deployed configuration in the patient's vasculature, the drug delivery mechanism including a drug, the drug delivery mechanism being configured to release an amount of the drug into blood flowing in the vasculature sufficient to facilitate maintaining patency of the filter during use of the filter in the patient's vasculature, the drug comprising an agent formulated to prevent blood clotting.
2. The vascular device of claim 1 , wherein the drug delivery mechanism is positioned proximal to the proximal end of the filter.
3. The vascular device of claim 1 , wherein the drug delivery mechanism is self-activating.
4. The vascular device of claim 3 , wherein the self-activating drug delivery mechanism includes a plurality of beads.
5. The vascular device of claim 4 , wherein the self-activating drug delivery mechanism is activated by piercing of the beads upon deployment of the vascular device.
6. The vascular device of claim 4 , wherein the self-activating drug delivery mechanism is activated by dissolving a coating applied to the beads.
7. The vascular device of claim 4 , wherein the filter is expandable about the hostwire.
8. The vascular device of claim 7 , wherein the plurality of beads are carried by the hostwire.
9. The vascular device of claim 8 , wherein the self-activating drug delivery mechanism is activated by releasing the beads from the hostwire and impacting the beads against the filtering surface of the filter.
10. The vascular device of claim 3 , wherein the self-activating drug delivery mechanism is a micro-electro mechanical system (MEMS).
11. The vascular device of claim 10 , wherein the MEMS dispenses the drug at predetermined intervals.
12. The medical device of claim 11 , wherein said MEMS is located on a hostwire extending proximate said distal member of said medical device.
13. The vascular device of claim 3 , wherein the self-activating drug delivery mechanism includes an expandable bladder and wherein the self-activating delivery mechanism is activated by expansion of the expandable bladder.
14. The vascular device of claim 6 , wherein the coating is dissolved by an activating agent in the blood of a patient.
15. The vascular device of claim 4 , wherein at least a portion of the beads are porous.
16. The vascular device of claim 4 , wherein at least a portion of the plurality of beads comprise a polymer.
17. The vascular device of claim 1 , wherein the drug is an anti-platelet agent.
18. The vascular device of claim 1 , wherein the drug is a IIb/IIIa inhibitor.
19. The vascular device of claim 1 , wherein the drug is a fibrinolytic drug.
20. The vascular device of claim 1 , wherein the drug is selected from heparin, Aggrastat and Integrilin.
21. A vascular protection device for use in the vasculature of a patient comprising:
a hostwire having a distal portion, the hostwire interposable in the vasculature of the patient;
an expandable filter attached to a distal portion of the hostwire, the filter being expandable from a collapsed delivery configuration to an expanded deployed configuration, the filter having a proximal end, a distal end and a filtering surface for allowing passage of blood therethrough; and
a drug delivery mechanism carried by the hostwire adjacent the distal portion of the hostwire, the drug delivery mechanism being positioned proximal to the distal end of the filter and being spaced apart from the filtering surface of the filter when the filter is in the expanded deployed configuration in the patient's vasculature, the drug delivery mechanism including a drug, the drug delivery mechanism being configured to release an amount of the drug into blood flowing in the vasculature sufficient to facilitate maintaining patency of the filter during use of the filter in the patient's vasculature, the drug comprising an agent formulated to prevent blood clotting,
wherein the drug delivery mechanism is self-activating,
wherein the self-activating drug delivery mechanism includes a plurality of beads, and
wherein the self-activating drug delivery mechanism is activated by piercing of the beads upon deployment of the vascular device.
22. The vascular device of claim 21 , wherein the drug delivery mechanism is positioned proximal to the proximal end of the filter.
23. The vascular device of claim 21 , wherein the filter is expandable about the hostwire.
24. The vascular device of claim 23 , wherein the plurality of beads are carried by the hostwire.
25. The vascular device of claim 21 , wherein at least a portion of the beads are porous.
26. The vascular device of claim 21 , wherein at least a portion of the plurality of beads comprise a polymer.
27. The vascular device of claim 21 , wherein the drug is an anti-platelet agent.
28. The vascular device of claim 21 , wherein the drug is a IIb/IIIa inhibitor.
29. The vascular device of claim 21 , wherein the drug is a fibrinolytic drug.
30. The vascular device of claim 21 , wherein the drug is selected from heparin, Aggrastat and Integrilin.
31. A vascular protection device for use in the vasculature of a patient comprising:
a hostwire having a distal portion, the hostwire interposable in the vasculature of the patient;
an expandable filter attached to a distal portion of the hostwire, the filter being expandable from a collapsed delivery configuration to an expanded deployed configuration, the filter having a proximal end, a distal end and a filtering surface for allowing passage of blood therethrough; and
a drug delivery mechanism carried by the hostwire adjacent the distal portion of the hostwire, the drug delivery mechanism being positioned proximal to the distal end of the filter and being spaced apart from the filtering surface of the filter when the filter is in the expanded deployed configuration in the patient's vasculature, the drug delivery mechanism including a drug, the drug delivery mechanism being configured to release an amount of the drug into blood flowing in the vasculature sufficient to facilitate maintaining patency of the filter during use of the filter in the patient's vasculature, the drug comprising an agent formulated to prevent blood clotting,
wherein the drug delivery mechanism is self-activating,
wherein the self-activating drug delivery mechanism includes a plurality of beads,
wherein the filter is expandable about the hostwire,
wherein the plurality of beads are carried by the hostwire, and
wherein the self-activating drug delivery mechanism is activated by releasing the beads from the hostwire and impacting the beads against the filtering surface of the filter.
32. The vascular device of claim 31 , wherein the drug delivery mechanism is positioned proximal to the proximal end of the filter.
33. The vascular device of claim 31 , wherein at least a portion of the beads are porous.
34. The vascular device of claim 31 , wherein at least a portion of the plurality of beads comprise a polymer.
35. The vascular device of claim 31 , wherein the drug is an anti-platelet agent.
36. The vascular device of claim 31 , wherein the drug is a IIb/IIIa inhibitor.
37. The vascular device of claim 31 , wherein the drug is a fibrinolytic drug.
38. The vascular device of claim 31 , wherein the drug is selected from heparin, Aggrastat and Integrilin.